CapsoVision (NASDAQ:CV) Stock Price Down 5.7% - What's Next?

Key Points

• Shares fell 5.7% intraday to $7.07, with about 128,347 shares traded (roughly 3% below average); the stock sits above its 50‑day MA ($6.14) and near its 200‑day MA ($6.60) with a market cap of ~$352M.
• Analyst sentiment is mixed but leans positive — consensus is a Moderate Buy with an average target of $8.50, while Benchmark cut its target from $14 to $10 and ratings are split (1 Strong Buy, 1 Buy, 1 Hold, 1 Sell).
• CapsoVision reported quarterly EPS of $0.02 on $3.92M revenue, yet analysts expect a -$0.49 EPS for the current year, and several institutional investors have recently opened or increased small positions in the stock.

CapsoVision, Inc. (NASDAQ:CV - Get Free Report) was down 5.7% during mid-day trading on Monday . The stock traded as low as $7.04 and last traded at $7.07. Approximately 128,347 shares changed hands during mid-day trading, a decline of 3% from the average daily volume of 132,398 shares. The stock had previously closed at $7.50.

Analyst Upgrades and Downgrades

CV has been the subject of several recent research reports. Wall Street Zen upgraded shares of CapsoVision to a "hold" rating in a research note on Saturday, January 10th. Benchmark decreased their target price on shares of CapsoVision from $14.00 to $10.00 and set a "speculative buy" rating for the company in a research note on Friday, March 27th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $8.50.

CapsoVision Price Performance

The firm has a market cap of $352.44 million and a price-to-earnings ratio of -3.23. The firm's 50 day moving average price is $6.14 and its two-hundred day moving average price is $6.60.

CapsoVision (NASDAQ:CV - Get Free Report) last announced its earnings results on Thursday, March 26th. The company reported $0.02 earnings per share for the quarter. The business had revenue of $3.92 million for the quarter. On average, analysts anticipate that CapsoVision, Inc. will post -0.49 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in CV. New York State Common Retirement Fund purchased a new position in CapsoVision during the third quarter worth about $34,000. Deutsche Bank AG purchased a new position in CapsoVision during the fourth quarter worth about $47,000. Wells Fargo & Company MN raised its holdings in CapsoVision by 66.4% during the fourth quarter. Wells Fargo & Company MN now owns 6,287 shares of the company's stock worth $67,000 after purchasing an additional 2,508 shares in the last quarter. Citadel Advisors LLC purchased a new position in CapsoVision in the third quarter valued at about $115,000. Finally, Virtu Financial LLC purchased a new position in CapsoVision in the fourth quarter valued at about $128,000.

CapsoVision Company Profile

CapsoVision, Inc NASDAQ: CV is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.